Institutional Ownership Chinook Therapeutics, Inc. (KDNY)
This table provides information about the institutional ownership of Chinook Therapeutics, Inc. (KDNY). We have compiled data on the 5 institutions that hold shares in the stock, with a total of 233,797 shares, which have been reported (via 13F filing form) to have a value of $0.
| Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
|---|---|---|---|---|---|
|
Tekla Capital Management LLC
|
Aug 10, 2023 Q2 2023 |
150,863
shares
|
$0
0.23% of portfolio
|
Q2 2023
Added 80.67%
|
|
|
Health Cor Management, L.P.
New York, NY |
Feb 14, 2023 Q4 2022 |
60,000
shares
|
$0
1.49% of portfolio
|
Q4 2022
Reduced 77.51%
|
|
|
Pictet Asset Management Sa
Geneva 73, V8 |
Aug 10, 2023 Q2 2023 |
22,829
shares
|
$0
0.0% of portfolio
|
Q2 2023
Reduced 98.06%
|
|
|
Farther Finance Advisors, LLC
San Francisco, CA |
Oct 28, 2024 Q3 2024 |
100
shares
|
$0
0.0% of portfolio
|
Q2 2024
New holding
|
|
|
Parallel Advisors, LLC
|
Aug 08, 2024 Q2 2024 |
5
shares
|
$0
0.0% of portfolio
|
Q3 2023
Reduced 80.77%
|